Future Directions in Polymer Colloids 1987
DOI: 10.1007/978-94-009-3685-0_22
|View full text |Cite
|
Sign up to set email alerts
|

Biomedical Applications of Monodisperse Magnetic Polymer Particles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
26
0

Year Published

1993
1993
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(26 citation statements)
references
References 22 publications
0
26
0
Order By: Relevance
“…In our experimental method we used the monomer The resulting particles have a coefficient of variation (CV) SOMOS 3100, which is commercially available from Duof 1% for particles of 10 mm in diameter (3).…”
Section: Introductionmentioning
confidence: 99%
“…In our experimental method we used the monomer The resulting particles have a coefficient of variation (CV) SOMOS 3100, which is commercially available from Duof 1% for particles of 10 mm in diameter (3).…”
Section: Introductionmentioning
confidence: 99%
“…Those microspheres were designed for cell labeling and biological detection. Ugelstad et al proposed an elaborate technology that was commercialized [7], but high cost prevents it from large-scale industrial application. Compared to previously described MMS, preparing MMS synthesized from biomaterials overcomes the cost problem and has good biocompatibility regarding the separation of medicine and biological materials.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4]. For that purpose, a huge amount of researches has been dedicated to the design and to the preparation of colloidal polymers with appropriate properties for interacting with biologically active macromolecules without significantly affecting the behavior of the two reagents, i.e., the colloidal stability in the case of the particles and the biological activity in the case of the biomolecules.…”
Section: Introductionmentioning
confidence: 99%